The new technology, called ZFDesign, is based on data generated by the screen of nearly 50 billion possible zinc finger-DNA interactions. According to the researchers, zinc finger editing could be a safer alternative to CRISPR gene editing.
The research team plans to make the model precise so that it can build more zinc-finger groupings, according to a Jan. 26 NYU Langone news release.
The study was funded through National Institutes of Health and Canadian Institutes of Health grants.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
